NSEUpdates8 Sept 2026 · 8 Sept 2026, 12:55 pm

Updates

Advanced Enzyme Technologies Limited · ADVENZYMES

✦ AI SummaryBuyback

Advanced Enzyme Technologies Limited has extinguished 8,25,028 equity shares bought back during the month of August 2026 through the open market route.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Advanced Enzyme Technologies Limited has informed the Exchange regarding 'Extinguishment of Equity Shares'.

Attachments (1)

📄

AETL_08092026125504_Intimation.pdf

pdf

Download →
View document text
September 08, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Rotunda Exchange Plaza, Plot No. C/1, G Block Building, Bandra-Kurla Complex, P.J. Towers, Dalal Street, Fort, Bandra (East), Mumbai- 400 051 Mumbai — 400 001 Symbol: ADVENZYMES Scrip Code: 540025 Dear Sir/Madam, Sub: Extinguishment of 8,25,028 (Eight Lakh Twenty Five Thousand and Twenty Eight) fully paid-up Equity Shares of the face value ₹ 2/- each (Rupees Two only) of Advanced Enzyme Technologies Limited (“Company”) consequent to the ongoing buyback from the open market route through the Stock Exchanges. Pursuant to the provisions of Regulations 11 read with Regulation 21 of the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018 as amended (“SEBI Buy-Back Regulations”) and pursuant to the Public Announcement dated August 10, 2026, we would like to inform that the Company has extinguished 8,25,028 (Eight Lakh Twenty Five Thousand and Twenty Eight) Equity Shares bought back during the month of August 2026 consequent to the ongoing buyback of its Equity shares under the open market route through Stock Exchanges. In connection with the above, copy of the following documents are enclosed: a. Certificate pursuant to Regulation 11 (iv) read with Regulation 24 (iv) of the SEBI Buy-Back Regulations certifying compliance with Regulation 11 read with Regulation 21 of the SEBI Buy Back Regulations (Certificate of extinguishment of equity shares bought back by the Company during August 2026). a. Debit confirmation from Central Depository Services (India) Limited for 8,25,028 (Eight Lakh Twenty Five Thousand and Twenty Eight) Equity shares in dematerialized form. This is for your information and records. Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head-Legal Encl: As above Shiv Hari Jalan & Co. Shiv Hari Jalan B.Com, F.C.A; F.C.S Company Secretaries Annexure 1 Advanced Enzymes Technologies Limited The Board of Directors Advanced Enzyme Technologies Limited A wing, Sun Magnetica, 5th Floor, Near LIC Service Road, Louiswadi, Thane 400604 Maharashtra Dear Sirs, 1. This report is issued in accordance with the terms of our service scope with Advanced Enzymes Technologies Limited(hereinafter the ). 2. At the request of the Company, we Equity Shares bought back by Advanced Enzymes Technologies Limited ), prepared by the Company and signed by us for identification purposes. The Statement has been prepared and this report is issued, in connection with Regulation 11 read with Regulation 21 of Securities Exchange Board of India (Buy-Back of Securities) Regulations, 2018 (hereinafter referred to as ). 3. Management is responsible for I. the preparation of the Statement including the preparation and maintenance of all accounting and other relevant supporting records and documents. This responsibility includes the design, implementation and maintenance of internal control relevant to the preparation and presentation of the Statement and applying an appropriate basis of preparation; and making estimates that are reasonable in the circumstances; II. complying with all the provisions of the Companies Act, 2013, the SEBI Buy Back Regulations and other applicable regulations/circulars issued by Securities and Exchange Board of India ( ) from time to time. 4. Pursuant to the requirements of the Company, our responsibility is to perform the procedures on the Statement and provide limited assurance. The procedures performed vary in nature and timing from, and are less in extent than for, a reasonable assurance and consequently, the level of assurance obtained in a limited assurance engagement is substantially lower than the assurance that would have been obtained had a reasonable assurance engagement been performed. Head Office:. 1055, Level 10, Hubtown Solaris, N.S.Phadke Marg, Andheri (East), Mumbai - 400069 Branch Office:. 104, Mahavir Building, 44/46, Kalbadevi Road, Mumbai - 400002 :. shivharijalancs@gmail.com, :.(022) 22075834, 22075835, 26836215, 9869035834 Shiv Hari Jalan & Co. Shiv Hari Jalan B.Com, F.C.A; F.C.S Company Secretaries 5. We have performed the following procedures on the Statement: 1202300001336714, opened and maintained by the Company with Emkay Global Financial Services Limited, inter-alia, giving the details of equity shares bought back during the month of August 2026 through the open market route through Stock Exchanges and the corresponding extinguishment done by Central Depository Services (India) Limited. II. We noted that the number of equity shares bought back during the month of August 2026 and number of equity shares extinguished are equal. III. We have received from the Company, a letter no. CDSL/OPS/IPO-CA/2026-27/CA- 776734.001 dated September 03, 2026 issued by Central Depository Services (India) Limited for extinguishment of equity shares of the Company bought back under the buy back offer. We relied on the letter as made available by the Company and have performed no independent procedures in this regard. IV. Verified that the number of equity shares extinguished by Central Depository Services (India) Limited tallies with the equity shares debited in the aforesaid depository account number, opened and maintained by the Company with Emkay Global Financial Services Limited. V. Performed necessary inquires with the management and obtained necessary representations from the management. depository account i.e.1202300001336714 for the buy back of equity shares. 7. We conducted our examination of the Statement in accordance with the Guidance Note issued by the Institute of Company Secretaries of India ( ). The Guidance Note requires that we comply with the ethical requirements of the Code of Ethics issued by the ICSI. Opinion 8. Based on the procedures performed by us and to the best of our knowledge and according to the information, explanations and representations given to us, nothing has come to our attention that causes us to believe that the equity shares bought back under the buyback offer, aggregating to 8,25,028 (Eight Lakh TwentyFive Thousand and Twenty Eight)have not been extinguished. Head Office:. 1055, Level 10, Hubtown Solaris, N.S.Phadke Marg, Andheri (East), Mumbai - 400069 Branch Office:. 104, Mahavir Building, 44/46, Kalbadevi Road, Mumbai - 400002 :. shivharijalancs@gmail.com, :.(022) 22075834, 22075835, 26836215, 9869035834 Shiv Hari Jalan & Co. Shiv Hari Jalan B.Com, F.C.A; F.C.S Company Secretaries Restriction on use 9. This Certificate has been issued at the request of the Company, solely in connection with the purpose mentioned above in Paragraph 2, and is not to be used or referred to for any other purpose or distributed to anyone without our prior written consent. Accordingly, Shiv Hari Jalan & Co., Practicing Company Secretariesdoesnot accept or assume any liability or any duty of care or for any other purpose or to any other person to whom this Certificate is shown or into whose hands it may come without prior consent in writing. ForShiv Hari Jalan & Co., Company Secretaries Firm Registration Number: S2016MH382700 Name:Shiv Hari Jalan Proprietor FCS No: 5703 C.P.NO: 4226 UDIN: F005703H001395696 Date: 07.09.2026 Place:Mumbai Peer Review Number: 1576/2021 Head Office:. 1055, Level 10, Hubtown Solaris, N.S.Phadke Marg, Andheri (East), Mumbai - 400069 Branch Office:. 104, Mahavir Building, 44/46, Kalbadevi Road, Mumbai - 400002 :. shivharijalancs@gmail.com, :.(022) 22075834, 22075835, 26836215, 9869035834 CDSL/OPS/IPO-CA/2026-27/CA-776734.001 September 03, 2026 The Company Secretary, Advanced Enzyme Technologies Limited 5th Flr, A-wing, Sun Magnetica Near Lic Service Road Louiswadi Thane (w), Mahahrashtra India - 400604 Dear Sir, Sub:- Buyback This is to inform you that the file uploaded by you / your RTA for the above-mentioned purpose, has been successfully processed at Central [Showing first 8,000 characters — download PDF for full document]